#placing
Latest news and interesting information about placing.
Creo Medical plans placing to raise £5.5m
Creo Medical announces a placing to raise £5.5m, with directors subscribing £2.15m. Q1 2026 revenue up 60% YoY.
$2.9B EXIM Loan Approved for Stibnite Project
Perpetua Resources secures $2.9 billion EXIM loan for Stibnite Gold Project. 13-year credit facility, repayments from 2030. Stock trades below fair value.
Oppenheimer Reaffirms Analog Devices Stock Rating
Oppenheimer reaffirms Outperform rating for Analog Devices (ADI) amid AI demand and strong quarterly results, with a $450 price target.
EasyJet H1 2026 Losses Widen, Shares Rise 2.18%
EasyJet H1 2026 pre-tax loss of £552 million; shares up 2.18%. EasyJet Holidays EBIT increases 50%. Fleet modernization and dividend yield details.
Wheels Up CEO Mattson buys $8,201 in company stock
Wheels Up CEO George Mattson buys $8,201 in company stock. Details on the purchase, fleet modernization, and reverse stock split.
Tredegar director sells $42,447 in stock
Tredegar director Carl E. Tack III sold $42,447 worth of stock. Shares trade at $7.66. Read more on Bond.az.
Intuit cuts 17% of global workforce
Intuit lays off 17% of its workforce, about 3,000 employees, to streamline operations and focus on AI. Severance details and industry context included.
Decolonization Means Putting People Above Systems
Finies Christian of the Bonaire Human Rights Organization explains decolonization as putting people above systems. The Baku conference discussed youth roles and climate change.
AI is coming, young people are booing
AI is coming, but young people are booing: news about AI impact, job cuts, and Gen Z's reaction.
Itron Stock Hits 52-Week Low at $78.50
Itron stock hits 52-week low at $78.50 with a 31.63% annual drop. Despite earnings beat, shares remain under pressure.
USA Today stock hits 52-week high at $7.68
USA Today stock hits 52-week high at $7.68. Market cap $1.12 billion. Bond.az analysis and latest news.
Avacta reports 2025 results, raises £32.5m for oncology trials
Avacta Group reports 2025 preliminary results, raises £32.5 million for oncology trials. Updates on AVA6103 and AVA6000 programs.
StanChart to cut 7,000 jobs, shift to AI
Standard Chartered plans to cut 7,000 jobs, shift to AI. The bank aims to reduce costs and boost profitability by 2030.
StanChart to Cut Over 7,000 Jobs by 2030
StanChart announces job cuts of over 7,000 by 2030, raises profitability target.
Banc of California SWOT Analysis: Growth Amid Challenges
Discover Banc of California's SWOT analysis: strengths, weaknesses, opportunities, and threats. Growth prospects and financial metrics detailed.
Middle East tension costs companies $25 billion
Middle East tension costs global companies $25 billion due to Strait of Hormuz, energy prices, and supply chain disruptions. Detailed analysis.
AI: Threat and Opportunity
Minister of Culture Adil Karimli emphasized that artificial intelligence is both a threat and an opportunity.
Lilac scent can cause serious health issues
Lilac scent can cause headaches, arrhythmia, and vision problems. Expert advises against keeping lilacs in the bedroom.
Intrepid Potash director sells $217,149 in stock
Intrepid Potash director Lori Lancaster sold $217,149 in company stock on May 12, 2026. Shares sold between $45.15-$45.31.
Khadija Gurbanzade wins silver at European Championship
Azerbaijani wrestler Khadija Gurbanzade wins silver at U-17 European Championship.
FHLB Chicago Issues $315M in New Debt
Federal Home Loan Bank of Chicago announces $315 million in new bond issuances. Read more at Bond.az.
Zanaga raises £4.2m for Congo project
Zanaga Iron Ore launches a £4.2 million fundraising for its Congo project through a share placing and subscription.
NewJersey Resources stock hits all-time high at $57.91
NewJersey Resources stock hits all-time high at $57.91. 30-year dividend growth streak and strong quarterly results.
Wall Street rises on tech strength, Trump-Xi summit
Wall Street opens higher driven by tech sector gains and the Trump-Xi summit. S&P 500, Nasdaq, and Dow Jones post gains.
H.C. Wainwright Reiterates Immunic Stock Rating
H.C. Wainwright maintains Buy rating and $22 price target on Immunic stock. The company awaits pivotal MS drug trial results. Read more on Bond.az.
Ali Cavadli wins gold at European Champs
Azerbaijani wrestler Ali Cavadli wins gold at U-17 European Championship. Team finishes third with 1 gold, 2 silver, 3 bronze medals.
...

























